Biotechnologie

Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.

24. Juni 2026 Von KI berichtet

Führende manager aus der pharma- und tech-branche schlagen alarm wegen möglicher missbrauchsrisiken von KI und gentechnik für biologische waffen.

Das ägyptische Projekt für Vaccine City und Biotechnologie wird bis 2030 voraussichtlich Investitionen in Höhe von 12 Milliarden EGP anziehen, so der Minister für Gesundheit und Bevölkerung.

9. Juni 2026 Von KI berichtet

A longevity startup has administered its first dose of a cellular rejuvenation therapy to a patient. The move follows recent FDA approval for human clinical trials of the treatment known as ER-100.

An experimental therapy called VERVE-102 lowered LDL cholesterol by up to 62 percent after a single dose in an early safety study. The results come from a Phase I trial involving 35 patients with high cholesterol or early cardiovascular disease. Data were published this week in the New England Journal of Medicine.

21. Mai 2026 Von KI berichtet Fakten geprüft

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.